Literature DB >> 28656374

[Risk of heart failure in patients with Hodgkin lymphoma after radiation and anthracycline chemotherapy].

J Kriz1, H T Eich2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28656374     DOI： 10.1007/s00066-017-1169-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.

Authors:  Bradford S Hoppe; Stella Flampouri; Zhong Su; Naeem Latif; Nam H Dang; James Lynch; Michael Joyce; Eric Sandler; Zuofeng Li; Nancy P Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-02       Impact factor: 7.038

2.  Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin's lymphoma: Comparison of ILROG IS-RT and the GHSG IF-RT.

Authors:  Jan Kriz; Max Spickermann; Philipp Lehrich; Heinz Schmidberger; Gabriele Reinartz; Hans Eich; Uwe Haverkamp
Journal:  Strahlenther Onkol       Date:  2015-04-16       Impact factor: 3.621

3.  Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma.

Authors:  Maja V Maraldo; Nils Patrik Brodin; Ivan R Vogelius; Marianne C Aznar; Per Munck Af Rosenschöld; Peter M Petersen; Lena Specht
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-21       Impact factor: 7.038

4.  Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.

Authors:  Theodore Girinsky; Richard van der Maazen; Lena Specht; Berthe Aleman; Philip Poortmans; Yolande Lievens; Paul Meijnders; Mithra Ghalibafian; Jacobus Meerwaldt; Evert Noordijk
Journal:  Radiother Oncol       Date:  2006-06-22       Impact factor: 6.280

5.  Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).

Authors:  Lena Specht; Joachim Yahalom; Tim Illidge; Anne Kiil Berthelsen; Louis S Constine; Hans Theodor Eich; Theodore Girinsky; Richard T Hoppe; Peter Mauch; N George Mikhaeel; Andrea Ng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-06-18       Impact factor: 7.038

6.  Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?

Authors:  Theodore Girinsky; Charlotte Pichenot; Anne Beaudre; Mithra Ghalibafian; Dimitri Lefkopoulos
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

7.  Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts.

Authors:  Carsten Nieder; Sabine Schill; Peter Kneschaurek; Michael Molls
Journal:  Radiother Oncol       Date:  2006-12-06       Impact factor: 6.280

8.  Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG).

Authors:  Hans Theodor Eich; Rolf-Peter Müller; Rita Engenhart-Cabillic; Peter Lukas; Heinz Schmidberger; Susanne Staar; Normann Willich
Journal:  Strahlenther Onkol       Date:  2008-08       Impact factor: 3.621
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.